It seems likely that the use of blockers of HSF1 activation/HSP induction, as it was done in models with CSCs [63] and non-stem cancer cells [96,97,98,99], would improve the beneficial effects of hyperthermia and proteasome inhibitors on CSCs. The gene discussed is HSP90B2P; the disease is cancer.